Kristina Melkersson

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: NEUROENDOCRINOLOGY LETTERS. 2023;44(6):358-367
Higher concentration in serum of insulin autoantibodies in patients with schizophrenia or related psychosis, compared to in control subjects
Melkersson K; Bensing S
Article: NEUROENDOCRINOLOGY LETTERS. 2023;44(1):39-54
Associations between heredity, height, BMI, diabetes mellitus type 1 or 2 and gene variants in the insulin receptor (INSR) gene in patients with schizophrenia.
Melkersson K; Persson B
Article: NEUROENDOCRINOLOGY LETTERS. 2022;43(1):1-8
Association between single nucleotide polymorphisms in non-coding regions of the insulin (INS) gene and schizophrenia
Melkersson K; Persson B
Article: NEUROENDOCRINOLOGY LETTERS. 2021;42(5):339-358
Increased antibody reactivity against insulin receptor-A and insulin like growth factor 1 receptor and their ligands in cerebrospinal fluid and serum of patients with schizophrenia or related psychosis
Melkersson K; Bensing S
Article: NEUROENDOCRINOLOGY LETTERS. 2020;41(5):245-254
Schizophrenia- or schizoaffective disorder diagnosis and the risk for subsequent type 1-or type 2 diabetes mellitus: a Swedish nationwide register-based cohort study
Melkersson K
Article: NEUROENDOCRINOLOGY LETTERS. 2019;40(3):125-134
Type 1 diabetes mellitus and the risk for schizophrenia or schizoaffective disorder: a Swedish nationwide register-based cohort study
Melkersson K; Wernroth M-L
Article: NEUROENDOCRINOLOGY LETTERS. 2018;39(5):371-379
Sequencing of the insulin receptor (INSR) gene reveals association between gene variants in exon and intron 13 and schizoaffective disorder
Melkersson K
Article: NEUROENDOCRINOLOGY LETTERS. 2018;39(1):33-42
Signs of impaired blood-brain barrier function and lower IgG synthesis within the central nervous system in patients with schizophrenia or related psychosis, compared to that in controls
Melkersson K; Bensing S
Article: NEUROENDOCRINOLOGY LETTERS. 2017;38(5):333-342
Early-onset inguinal hernia as risk factor for schizophrenia or related psychosis: a nationwide register-based cohort study
Melkersson K; Wernroth M-L
Article: NEUROENDOCRINOLOGY LETTERS. 2015;36(5):465-480
Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics
Melkersson K; Lewitt M; Hall K
Article: NEUROENDOCRINOLOGY LETTERS. 2013;34(3):173-176
Case report of a patient with schizophrenia and a mutation in the insulin receptor substrate-4 gene
Melkersson K
Article: NEUROENDOCRINOLOGY LETTERS. 2012;33(5):493-498
Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine
Feng S; Melkersson K
Article: NEUROENDOCRINOLOGY LETTERS. 2012;33(3):321-330
Evidence for a negative association between schizophrenia and a polymorphism in the insulin receptor substrate-3 (IRS-3) gene
Melkersson K; Persson B
Article: NEUROENDOCRINOLOGY LETTERS. 2011;32(1):51-58
The insulin receptor substrate-4 (IRS-4) gene and schizophrenia: no evidence for a main genetic factor, however one report of a single schizophrenia patient with a mutation.
Melkersson K; Persson B; Hongslo T
Article: NEUROENDOCRINOLOGY LETTERS. 2011;32(4):428-436
Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses
Melkersson K; Berinder K; Hulting A-L
Article: NEUROENDOCRINOLOGY LETTERS. 2011;32(5):634-640
Association between body mass index and insulin receptor substrate-4 (IRS-4) gene polymorphisms in patients with schizophrenia
Melkersson K; Persson B
Article: ACTA NEUROPSYCHIATRICA. 2009;21(1):4-10
Familial and sporadic schizophrenia: a comparison of somatic diseases and abuse in patients and their relatives
Melkersson K
Article: NEUROENDOCRINOLOGY LETTERS. 2009;30(3):343-351
Serotonin receptor 2A gene polymorphisms and schizophrenia: association with family history, diagnostic subtype and height in patients
Melkersson K; Hulting A-L
Article: NEUROENDOCRINOLOGY LETTERS. 2007;28(6):854-860
Effects of the atypical antipsychotic clozapine on insulin release in vitro
Melkersson K; Jansson E
Article: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2006;30(7):1277-1282
Serum creatine kinase levels in chronic psychosis patients - a comparison between atypical and conventional antipsychotics
Melkersson K
Article: NEUROENDOCRINOLOGY LETTERS. 2005;26(3):205-208
The atypical antipsychotics quetiapine, risperidone ziprasidone do not increase insulin release in vitro
Melkersson K; Jansson E
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2004;14(2):115-119
Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro
Melkersson K
Article: PSYCHOSOMATICS. 2002;43(1):67-70
Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine
Melkersson K; Hulting AL
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2001;11(5):327-332
Different effects of antipsychotic drugs on insulin release in vitro
Melkersson K; Khan A; Hilding A; Hulting AL
Article: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2000;250(1):6-10
Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder
Melkersson K; Hulting AL
Article: NEUROENDOCRINOLOGY LETTERS. 1999;20(3-4):199-204
Hormonal evaluation in schizophrenic patients treated with neuroleptics.
Melkersson K; Hulting A-L; Hall K
Visa fler

Alla övriga publikationer

Editorial comment: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2010;34(8):1365-1366
Introduction: Clinical findings related to alterations of the intracellular calcium homeostasis in schizophrenia
Melkersson K
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S432
Effects of the atypical antipsychotic clozapine on insulin release in vitro
Melkersson K; Jansson E
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2006;16:S84
Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite
Melkersson K
Published conference paper: JOURNAL OF CLINICAL PSYCHIATRY. 2005;66(6):761-767
Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients
Melkersson K
Review: DRUGS. 2004;64(7):701-723
Adverse metabolic effects associated with atypical antipsychotics - Literature review and clinical implications
Melkersson K; Dahl ML
Letter: JOURNAL OF CLINICAL PSYCHIATRY. 2001;62(11):903-904
Body weight gain, insulin, and leptin in olanzapine-treated patients - Reply
Melkersson K; Hulting AL; Brismar K
Doctoral thesis: 2000
Influence of antipsychotic drugs on hormone levels
Melkersson K

Anställningar

Anknuten till Forskning, Molekylär medicin och kirurgi, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, inriktning: psykiatri, Karolinska Institutet, 2008
MEDICINE DOKTORSEXAMEN, Institutionen för molekylär medicin och kirurgi, Karolinska Institutet, 2000

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI